Tagrisso is associated with positive outcomes among patients with unresectable stage 3 EGFR-mutant non-small cell lung cancer ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and ...

GlobalData predicts that tirzepatide is likely to be increasingly prescribed for broader cardiometabolic disease.

Bristol Myers BMY announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency (“EMA”) has recommended approval of Opdivo (nivolumab) for another ...

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...

Colorectal cancer is a serious but preventable disease if detected early. Advances in diagnostics, such as biomarker analysis ...

The evolution of genomic medicine is driving personalized healthcare, integrating AI and sequencing technologies for improved ...

Apellis' Empaveli receives FDA Priority Review for rare kidney diseases C3G and IC-MPGN. Phase 3 data show strong efficacy in proteinuria reduction.

Dr Sanjay Agrawal applies for patent for a specialized formulation for CKD related nutritional deficiencies: Shardul Nautiyal, Mumbai Wednesday, April 2, 2025, 08:00 Hrs [IST] Dr ...